POVOFORTAY® (POVORCITINIB) APPROVED IN EUROPE AS THE FIRST ONCE-DAILY ORAL TREATMENT FOR ADULTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA

Reuters · 2d ago

Please log in to view news